Breakthrough invasive fungal infections (IFI s) have emerged as a significant problem in
patients receiving systemic antifungals; however, consensus criteria for defining …

Solid organ transplant (SOT) recipients have a significant risk of invasive fungal diseases
(IFD) caused mainly by Candida spp. and Aspergillus spp. Candida spp. is the most frequent …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

These updated AST‐IDCOP guidelines provide information on epidemiology, diagnosis, and
management of Aspergillus after organ transplantation. Aspergillus is the most common …

Abstract Background. Invasive fungal infections (IFIs) are a major cause of morbidity and
mortality among organ transplant recipients. Multicenter prospective surveillance data to …

Scope Presenting symptoms, distributions and patterns of diseases and vulnerability to
invasive aspergillosis (IA) are similar between children and adults. However, differences …

Morbidity and mortality caused by invasive Aspergillus infections are increasing. This is
because of the higher number of patients with malignancies treated with intensive …

The field of cardiothoracic transplantation (CT) has evolved significantly, but infections
remain an important cause of morbidity and mortality, particularly fungal infections (FIs). The …

Infectious diseases after solid organ transplantation (SOT) are a significant cause of
morbidity and reduced allograft and patient survival; however, the influence of infection on …

Invasive aspergillosis (IA) occurs in 1–15% of the solid organ transplant (SOT) recipients.
Mortality rate in transplant recipients with IA historically has ranged from 65% to 92%(1, 2, 3 …